<DOC>
	<DOCNO>NCT00362245</DOCNO>
	<brief_summary>The limited available data precludes establish antibiotic regimen patient suffer bacterial meningitis head trauma , spontaneous bleed Understanding disposition Amikacin administer intrathecally enable propose rational treatment patient .</brief_summary>
	<brief_title>Amikacin Penetration Into Cerebrospinal Fluid</brief_title>
	<detailed_description>The limited available data precludes establish antibiotic regimen patient suffer bacterial meningitis head trauma , spontaneous bleed Understanding disposition Amikacin administer intrathecally enable propose rational treatment patient .</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Bacterial</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>1 . Culture prove bacterial meningitis prescribe therapy include use systemic intraventricular amikacin therapy . 2 . The included patient intraventricular catheter place intraventricular pressure measurement admit intensive care unit . 3 . Blood creatinine concentration 1.49 mg/dL measure inclusion day . 1 . Patients legal guardian refuse participate study . 2 . Known allergy amikacin . 3 . Blood creatinine concentration 1.5 mg/dL high . 4 . Subjects without intraventricular catheter need repeat lumbar puncture CSF amikacin determination . 5 . Patients suffer know chronic liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Amikacin</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Intra-Thecal injection</keyword>
</DOC>